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Abstract
Background: Sterile alpha motif (Sam) domains are small protein modules that can be involved in
homotypic or heterotypic associations and exhibit different functions. Previous studies have
demonstrated that the Sam domain of the lipid phosphatase Ship2 can hetero-dimerize with the
Sam domain of the PI3K effector protein Arap3.
Results:  Here, we determine the NMR solution structure of Arap3-Sam and implement a
multidisciplinary approach consisting of NMR spectroscopy, ITC (Isothermal Titration
Calorimetry), mutagenesis and molecular modeling studies to analyze the interaction between
Ship2-Sam and Arap3-Sam. This work reveals that Arap3-Sam may associate with Ship2-Sam by
adopting a binding mode common to other Sam domains. This binding mode is identical to what
we have very recently observed for the association between Ship2-Sam and the Sam domain from
the Ephrin A2 receptor.
Conclusion: Our studies further clarify the structural features that are relevant for Sam-Sam
interactions involving Ship2 and give additional hints that could be used for the identification of new
molecules able to selectively inhibit Sam-Sam associations.
Background
Arap3 is a protein involved in phospatidylinositol 3
kinase (PI3K) signaling pathways linked to regulation of
the actin cytoskeleton, cell spreading and the formation of
lamellipodia [1,2]. It works as a GTP-ase activator protein
(GAP) for the small G-proteins Arf and Rho [2]. Previous
studies have reported that Arap3 binds Ship2 (Src homol-
ogy 2 domain-containing phosphoinositide-5-phos-
phatase 2) by forming a hetero-dimer via the sterile alpha
motif domains (Sam) of both proteins [3]. The dissocia-
tion constant for this complex is about 100 nM as deter-
mined by previous Isothermal titration Calorimetry (ITC)
studies [3].
Although the consequences of the interaction between the
Sam domains of Arap3 (Arap3-Sam) and Ship2 (Ship2-
Sam) are not completely clear, it has been speculated that
the heterotypic Sam-Sam association may be used by
Arap3 to link a negative regulator of PI3K signaling (i.e.,
Ship2) to the effector complex [3]. In fact, while Arap3
needs to bind phosphatidylinositol(3,4,5)P3
(PtIns(3,4,5)P3) with one of its pleckstrin homology
(PH) domains to migrate to the plasma membrane and be
activated [4]; Ship2, by converting PtIns(3,4,5)P3 to
phosphatidylinositol(3,4)P2 (PtIns(3,4)P2), works as an
inhibitor of PI3K regulated pathways [5,6].
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Here, we report on structural and binding studies of
Arap3-Sam and Ship2-Sam. First, we determined the NMR
solution structure of the Sam domain of Arap3 and char-
acterized its interaction site for Ship2-Sam. Furthermore,
we also established the binding site of Ship2-Sam for
Arap3-Sam. Based on our observations, we speculate that
the Ship2-Sam/Arap3-Sam complex may adopt the ML
(Mid Loop)/EH (End Helix) interaction model that is
common to many Sam/Sam associations [7-9]. For exam-
ple, we recently reported on a similar binding mode
involving Ship2-Sam and the Sam domain from the
Ephrin A2 receptor (EphA2-Sam) [10], a Sam-Sam associ-
ation that is important to regulate receptor endocytosis
[11]. In agreement with these data, our NMR displace-
ment experiments confirmed that Arap3-Sam and EphA2-
Sam compete for a common binding site on the surface of
Ship2-Sam.
Our studies further clarify the structural features that are
important for Sam-Sam interactions involving Ship2 and
give additional hints useful for identifying new molecules
able to selectively inhibit Sam-Sam associations.
Results
NMR Solution Structure of Arap3-Sam
The aggregation state of Arap3-Sam in solution was ana-
lyzed by means of analytical ultracentrifugation studies
and backbone 15N R1 and R2 nuclear spin relaxation rates
measurements.
Arap3-Sam has a rotational correlation time τc estimated
by the R2/R1 average value of 7.7 ± 0.7 ns at a protein con-
centration of 150 μM which increases only slightly to 8.2
± 0.4 ns at the concentration of 1.4 mM. The Arap3-Sam
τc value is indeed similar to those reported for other Sam
domains, including Ship2, which only weakly self-associ-
ate [10,12,13]. On the contrary, the τc of Ship2-Sam
bound to Arap3-Sam is 11 ± 1 ns, this higher value reflects
the increase of the molecular weight caused by the Sam-
Sam association and points towards the formation of a
dimer [10,13,14].
Analytical ultracentrifugation measurements show that
Arap3-Sam is a monomer in solution, in fact the experi-
mentally measured molecular weight (10.84 kDa) is in
perfect agreement with the expected molecular weight.
Moreover, no concentration dependent changes can be
noticed in [1H,  15N]-HSQC spectra of Arap3-Sam
recorded at protein concentrations of 150 μM or 1.4 mM.
The solution structure of Arap3-Sam corresponds to a
canonical Sam domain fold (Figure 1, right panel). Rele-
vant structural parameters are reported in Table 1. Dis-
tance and angle constraints are well satisfied in the
ensemble of structures (Table 1), and the conformers con-
verge well (Figure 1, left panel) as demonstrated by the
low root-mean-square deviation (rmsd) values evaluated
for the residues of the core domain (Table 1).
Ship2-Sam/Arap3-Sam Binding Studies
The interaction between Ship2-Sam and Arap3-Sam was
analyzed by means of chemical shift perturbation studies
with 2D [1H,  15N]-HSQC experiments [15,16]. First, to
map the Ship2-Sam binding interface for Arap3-Sam, 2D
[1H, 15N]-HSQC spectra of a 15N uniformly labeled Ship2-
Sam sample were acquired in presence and absence of
unlabeled Arap3-Sam (Figure 2A). Normalized chemical
shift variations were then evaluated with the equation Δδ
= [(ΔHN)2 + (0.17 × Δ15N)2]1/2 (Figure 2B) [17]. The larg-
est Δδ (values > 0.1 ppm) were mainly found in the mid-
dle part of the protein, including the α 3 and α 4 helices,
the C-terminal portion of α 2 helix, and the close loop
regions (Figure 2B, C).
To identify the binding interface of Arap3-Sam for Ship2-
Sam, titration experiments were carried out with 15N
Table 1: Statistics for the NMR ensemble of Arap3-Sam
NOE upper distance limits 1127
Angle constraints 352
Residual target function, Å2 1.16 ± 0.15
Residual NOE violations
Number > 0.1 Å# 3
Residual angle violations
Number, >5° # 0
Atomic pairwise RMSD, Å
Backbone atoms
(aa 27-84)
0.26 ± 0.10
Heavy atoms
(aa 27-84)
0.75 ± 0.09
Ramachandran analysis @
Residues in core regions 87.2%
Residues in allowed regions 12.2%
Residues in generous regions 0.0%
Residues in disallowed regions 0.6%
# Mean CYANA [30] violations
@ PROCHECK_NMR [34] statistics for residues 27-87BMC Structural Biology 2009, 9:59 http://www.biomedcentral.com/1472-6807/9/59
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labeled Arap3-Sam and unlabeled Ship2-Sam (Figure 3A).
The residues of Arap3 that were greatly perturbed by the
interaction were assessed by analyzing the normalized
chemical shift deviations (Figure 3B). The largest varia-
tions were observed at the α 5 helix and the adjacent α1α2
and α 4α 5 loop regions (Figure 3B, C, D).
The chemical shift mapping results were further sup-
ported by isothermal titration calorimetry studies with the
Ship2-peptide Ac-EGLVHNGWDDLEFLSDITEEDL-NH2
(Shiptide) that we have previously identified [10]. This
peptide encompasses a region of Ship2-Sam (amino acids
from 43 to 64) highly affected by chemical shifts varia-
tions upon binding to Arap3-Sam (Figure 2C, left panel).
ITC measurements proved that the Shiptide could interact
with Arap3-Sam with a dissociation constant Kd of 40 ± 7
μM, a single binding site model (binding stoichiometry n
= 0.8 ± 0.1), binding enthalpy ΔH = -2602 ± 922 cal/mol
and entropy change ΔS = 11 ± 3 cal/(mol K) (Figure 2D
and Additional File 1).
Molecular modelling studies were also performed with
the software Haddock 1.3 [18] to generate a model of the
Ship2-Sam/Arap3-Sam complex (see Materials and Meth-
ods section for details on the docking procedure). The best
Haddock solution (i.e., the one with the lowest Haddock
score) is shown in Figure 4. The dimer interface is mainly
stabilized by electrostatic interactions in between acidic
residues of Ship2-Sam and basic residues of Arap3-Sam
(Figure 4). This model has been further confirmed by
mutagenesis studies. To this end, an Arap3-Sam triple
mutant was designed with the positively charged residues
H37, R77 and R80 replaced by negatively charged Asp res-
idues. This mutant fails to bind Ship2-Sam with high
affinity as evaluated by chemical shift perturbation studies
(See Additional File 2).
NMR displacement experiment
To assess if Arap3-Sam could compete with EphA2-Sam
for the same binding site of Ship2-Sam, we performed 2D
[1H,  15N]-HSQC displacement experiments [19] (See
Additional File 3). We first recorded a spectrum of 15N
labeled EphA2-Sam in its apo form. Then, we added to
this sample unlabeled Ship2-Sam in order to observe
changes in the 2D [1H, 15N]-HSQC indicative of the for-
mation of the Ship2-Sam/EphA2-Sam complex. The spec-
Solution Structure of Arap3-Sam Figure 1
Solution Structure of Arap3-Sam. Left panel. Superposition on the backbone atoms (residues 27-84) of the 20 NMR struc-
tures of Arap3-Sam. The flexible C-terminal tail (residues 88-100) has been omitted for clarity. The final structure calculation 
includes 1127 upper distance limits (382 intra-residue, 215 short-range, 252 medium-range, 278 long-range), 352 angle con-
straints and stereospecific assignments for the methyl groups of L33, L38, L50, L59, L64, L67, L79, L81, L82 and V36. Right 
panel. Ribbon drawing of the Arap3-Sam NMR conformer with the lowest CYANA target function. It presents the following 
secondary structure elements: α 1 (residues 29-36), α 2 (residues 39-47), α 3 (residues 53-56), α 4 (residues 61-67), α 5 (res-
idues 72-82).BMC Structural Biology 2009, 9:59 http://www.biomedcentral.com/1472-6807/9/59
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trum of unbound EphA2-Sam could be restored by
addition of unlabeled Arap3-Sam (final ratio EphA2-Sam/
Ship2-Sam/Arap3-Sam equal to 1:1.8:3.2) (Additional
File 3), thus demonstrating dissociation of the Ship2-
Sam/EphA2-Sam complex due to the capture of Ship2-
Sam by Arap3-Sam.
Discussion
Sam domains are small protein modules that act in several
biological events and can form homotypic or heterotypic
associations [20,21]. The lipid phosphatase Ship2 [5,6]
contains a Sam domain at its C-terminus. Binding part-
ners of this Sam domain have been only recently reported
and consist of the Sam domain from the EphA2 receptor
[11] and the Sam domain from the PI3K effector protein
Arap3 [3]. The NMR solution structure of Ship2-Sam (pdb
code: 2K4P) has been recently determined in our labora-
tory [10]. We have also investigated the interaction
between Ship2-Sam and EphA2-Sam by means of ITC and
NMR chemical shift perturbation studies [10]. ITC data
Mapping the Ship2-Sam binding interface for Arap3-Sam Figure 2
Mapping the Ship2-Sam binding interface for Arap3-Sam. A. Overlay of [1H, 15N]-HSQC spectra of 15N labeled Ship2-
Sam (200 μM) in absence (magenta) and presence (cyan) of unlabeled Arap3-Sam (233 μM). B. Graph reporting the normalized 
chemical shift deviations (Δδ = [(ΔHN)2 + (0.17 * Δ15N)2]1/2) versus the residue number. Residues E26, S30, L45, H47, N48, 
W50, D51, L53, E54, F55, L56, S57, D58, I59, T60, D63, L64, E66, A67, V69, L82, L84 show normalized deviations with values 
higher that 0.1 ppm. Residues 29 and 71 have not been reported due to spectral overlaps. C. Amino acids with normalized 
chemical shifts deviations (Δδ values) greater than 0.1 ppm are colored in cyan on the 3D solution structure of Ship2-Sam (con-
former number 1, pdb code: 2K4P[10]) in its ribbon (left panel) and surface (right panel) representations. The peptide region 
corresponding to the Shiptide is underlined in the left panel. D. ITC data showing the Arap3-Sam (75 μM) titration with the 
Shiptide peptide (1 mM). The solid line in the lower panel represents the fit of the calorimetric data to a single binding site 
model.BMC Structural Biology 2009, 9:59 http://www.biomedcentral.com/1472-6807/9/59
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Mapping the Arap3-Sam binding interface for Ship2-Sam Figure 3
Mapping the Arap3-Sam binding interface for Ship2-Sam. A. Superposition of [1H, 15N]-HSQC spectra of 15N labeled 
Arap3-Sam (100 μM concentration) in the apo form (green) and after addition of unlabeled Ship2-Sam (200 μM) (orange). B. 
Histogram of normalized chemical shift deviations (Δδ = [(ΔHN)2 + (0.17 * Δ15N)2]1/2) as function of the residue number. Δδ 
values > 0.1 ppm are observed for residues D26, H37, L38, E39, Q40, Y41, I69, S70, A71, H74, R75, K76, R77, I78, L79, R80, 
L81, Q83, T84, G85. Residues T72 and G73 have been omitted from the graph since the corresponding peaks can only be seen 
in the spectrum of the bound form. C. Ribbon drawing of Arap3-Sam (conformer number 1 of the NMR ensemble, pdb code: 
2KG5) where the residues with the largest normalized chemical shift deviations (Δδ values > 0.1 ppm) are colored in orange; 
the side chains of the residues that we mutated, are also shown. D. Surface representation of Arap3-Sam in the same orienta-
tion and colored as in panel C.BMC Structural Biology 2009, 9:59 http://www.biomedcentral.com/1472-6807/9/59
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have shown that the Sam domain of Ship2 binds to the
Sam domain of the EphA2 receptor with a dissociation
constant Kd = 0.75 ± 0.12 μM and a 1:1 binding stoi-
choimetry [10].
To gain additional insights into the structural determi-
nants characteristic of the Sam-Sam interactions which
involve Ship2, we have now performed similar structural
and binding studies on the association of Ship2-Sam with
Arap3-Sam. ITC data by Ramajjmaker et al. [3] have
already reported a Kd value of about 100 nM and a single
binding site model for this interaction.
The solution structure of Arap3-Sam consists of a small
five helix bundle and represents a classical Sam-domain
fold (Figure 1). In fact, Arap3-Sam presents highest
sequence homology with the Sam domain of Arap2 (pdb
code: 1X40, Riken Structural Genomics Initiative) as
shown by a blastp [22] search of the Arap3-Sam primary
sequence  versus  the Protein Data Bank (pdb) database
[23]. Sequence similarities with Ship2-Sam (pdb code:
2K4P[10]) and EphA2-Sam (pdb code: 2E8N, Riken Struc-
tural Genomics Initiative) are also relatively high (49%
and 58% respectively) (Figure 4, upper panel). Previous
studies have already reported that like Ship2-Sam, Arap3-
Sam does not have a strong propensity to self-associate
and prefers to be involved in heterotypic interactions [3].
Our  15N R1 and R2 relaxation measurements together
with analytical ultracentrifugation studies, further vali-
date these findings.
Docking Studies Figure 4
Docking Studies. Upper panel. Sequence alignment, generated with ClustalW2 [36] of Ship2-Sam, EphA2-Sam and Arap3-
Sam. Residues in the helices are colored in blue on the primary sequence of Ship2-Sam and red on the primary sequences of 
EphA2-Sam and Arap3-Sam. The Shiptide region is indicated. Underlined residues on the EphA2-Sam and Arap3-Sam 
sequences are the amino acids used in mutagenesis studies (See also [10]). Lower panel. Comparison between the best scoring 
Haddock [18] models of the EphA2-Sam/Ship2-Sam (Haddock score: -81.76) [10] (left) and Arap3-Sam/Ship2-Sam complexes 
(Haddock score: -150.72) (right). Residues which are most affected by binding in our chemical shifts perturbation studies (Δδ > 
0.1 ppm) have been colored in yellow on the ribbon representations of the molecules. The side chains of the residues that may 
contribute to important interactions at the dimer interface are shown as neon representation.BMC Structural Biology 2009, 9:59 http://www.biomedcentral.com/1472-6807/9/59
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Chemical shift mapping studies indicate that the interac-
tion surface of Ship2-Sam for Arap3-Sam is mainly made
up of the central regions of the protein (Figure 2). This is
the same area that we identified as responsible for the
binding of Ship2-Sam to EphA2-Sam (Figure 4). The Ship-
tide, a 22 residue long Ship2-Sam peptide, representing
the minimal Ship2-Sam region capable of binding to
EphA2-Sam, retains some ability to bind Arap3-Sam as
shown by ITC (Figure 2D). In the case of Arap3-Sam/Ship-
tide interaction, enthalpic contributions are responsible
for ~44% of the free energy of binding (ΔH = -2.6 kcal/
mol, ΔG = -5.9 kcal/mol) whereas for EphA2-Sam/Ship-
tide interaction [10] the enthalpy contributes only ~22%
to the free energy of binding (ΔH = -1.4 kcal/mol, ΔG = -
6.5 kcal/mol). Thus, in the Arap3-Sam/Shiptide complex
hydrogen bonding and electrostatic interactions are more
predominant.
In addition, NMR displacement experiments clearly show
that Arap3-Sam and EphA2-Sam compete for the same
binding site on the surface of Ship2-Sam (Additional File
3).
The binding area of Arap3-Sam for Ship2-Sam is primarily
made up of the C-terminal α 5 helix and adjacent loop
regions (Figure 3). Again, the location of this binding site
closely resembles the interaction surface of EphA2-Sam
for Ship2-Sam. From these binding data, we conclude that
Ship2-Sam and Arap3-Sam most likely interact by using
the Mid-Loop (ML)/End-Helix (EH) Model that is com-
mon among Sam-Sam associations [8,24,25] and where
Ship2-Sam and Arap3-Sam are providing the Mid-Loop
and End-Helix interfaces respectively (Figure 4). The same
interaction mode has been previously proposed by us for
the interaction between Ship2-Sam and EphA2-Sam.
A model of the Ship2-Sam/Arap3-Sam complex was gen-
erated with the software Haddock 1.3 [18] by using chem-
ical shift perturbation data (Figure 4). The best scoring
solution represents well the ML/EH topology that is
present in other experimental structure of Sam-Sam com-
plexes [8,25].
The binding site of Ship2-Sam for Arap3-Sam contains
many negatively charged residues, while the EH interface
of Arap3-Sam includes several positively charged amino
acids. As a consequence, this model appears largely stabi-
lized by electrostatic interactions (Figure 4). In fact, by
destroying some of these interactions through simultane-
ous mutation of the positively charged Arap3-Sam resi-
dues H37, R77 and R80 to aspartic acids, the binding to
Ship2-Sam is abolished or at least highly attenuated as
shown by NMR binding data (Additional File 2).
A very similar interaction model has been obtained by us
for the Ship2-Sam/EphA2-Sam association, by means of
docking procedures [10] (Figure 4). The pattern of interac-
tions at the dimer interface is analogous in the two com-
plexes (Figure 4). It is worth noting that in the Ship2-Sam/
EphA2-Sam model the EphA2-Sam residue Y81 may form
a stacking π-π interaction with the Ship2-Sam residue F55
that can be replaced by the cation-π interaction between
the Arap3-Sam residue R80 and F55 of Ship2 in the com-
plex Ship2-Sam/Arap3-Sam. Furthermore, in the Ship2-
Sam/Arap3-Sam complex H61 of Arap3-Sam could pro-
vide an additional electrostatic interaction with D63 of
Ship2-Sam that is not permitted in the Ship2-Sam/EphA2-
Sam dimer (Figure 4). These observations may reflect the
relatively stronger binding observed between Arap3-Sam
and Ship2-Sam (Kd = ~0.1 μM [3]) compared to the bind-
ing of EphA2-Sam to Ship2-Sam (Kd = 0.75 ± 0.12 μM) as
well as the better Haddock score for the Arap3-Sam/
Ship2-Sam model (Figure 4, lower panel).
Conclusion
We have described the 3D solution structure of Arap3-
Sam and reported on binding studies with Ship2-Sam.
Our work leads us to hypothesize that the interaction
mode of these two Sam domains is best described by the
canonical Mid-Loop/End-Helix model [8,24-26] in which
Ship2-Sam and Arap3-Sam are providing the Mid-Loop
and End-Helix interfaces respectively. A similar model has
been recently suggested by us for the interaction in
between Ship2-Sam and EphA2-Sam [10]. Our studies
also show that Arap3-Sam competes with EphA2-Sam for
binding to Ship2-Sam. Together with binding studies on
the Shiptide peptide, our results provide a framework
onto which one could envision designing novel molecular
probes able to selectively interfere with either the Ship2-
Sam/EphA2-Sam or with the Ship2-Sam/Arap3-Sam asso-
ciations.
Methods
Protein expression
Ship2-Sam and EphA2-Sam were expressed as previously
reported [10]. A synthetic genes construct containing resi-
dues from 1 to 80 of human Arap3 (UniprotKB/TrEMBL
code: Q8WWN8), encompassing the Sam domain (resi-
dues from 4 to 68), was purchased from Celtek (Nashville,
TN). Genes were cloned into the PET15b plasmid and
transformed using BL21-Gold (DE3) competent cells
(Stratagene).
The PET15b plasmid carrying genes for the Arap3-Sam tri-
ple mutant (H37D, R77D, R80D) was purchased from
Celtek (Nashville, TN). These protein constructs have
each an N-terminal 6His-tag (See Additional File 4).BMC Structural Biology 2009, 9:59 http://www.biomedcentral.com/1472-6807/9/59
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Unlabeled proteins were expressed at 37°C in LB
medium. Protein over-expression was induced at OD600 =
0.6 for 4 hours with isopropyl β-D-thiogalactopyranoside
(IPTG) at 1 mM concentration. Expression of 15N/13C
double labeled and 15N labeled proteins was carried out
in M9 minimal medium containing 2 g/l of 13C-Glucose
and/or 0.5 g/l of 15NH4Cl. 10% fractional 13C labeling for
stereo-specific assignments of Leu-CH3
δ1,2/Val-CH3
γ1,2
methyl groups [27] was obtained by adding 3.6 g of 12C-
glucose (natural abundance) and 0.4 g of 13C-glucose to
the M9 medium.
After dissolving the pellet in the following buffer: 50 mM
Tris (pH = 8), 500 mM NaCl, 5 mM imidazole, cell were
harvested by sonication. The protein was purified on a
nickel column (His-trap TM FF, 5 ml, Amersham) by
using an AKTA prime plus FPLC system; the elution buffer
consisted of 50 mM Tris (pH = 8), 500 mM NaCl, 200 mM
imidazole. To avoid non-specific interactions with the
Shiptide during ITC experiments, the His-tag tail of Arap3-
Sam was cut away from the protein by incubating it over-
night at 4°C with thrombin. The thrombin was then
removed with a benzamidine column (FF (HS), 1 ml,
Amersham).
The protein concentration was estimated by a nanodrop
ND-1000 spectrometer.
Resonance assignments of Arap3-Sam
Experiments for resonance assignments were recorded at
25°C on a Bruker Avance 600 MHz or a 700 MHz Bruker
AvanceIII spectrometers both equipped with TCI cryo-
probes. NMR samples consisted of 15N or 15N/13C labeled
Sam domains (1 mM) in phosphate buffer saline (PBS,
11.9 mM phosphate, 137 mM NaCl, 2.7 mM KCl) (Fisher
Scientific) at pH = 7.7 with 0.3% NaN3. Sample volumes
of 500 μl (95% H2O/5% D2O) were used. The Bruker soft-
ware Topspin version 2.0 was implemented to process
NMR spectra; NEASY [28]http://www.nmr.ch/ was used
to analyze the data.
Backbone assignments were obtained by analyzing triple
resonance experiments (HNCA, HNCACB, HNCO) [29].
The (H)CC(CO)NH spectrum was used to assign carbon
side chains. Comparison of 3D 15N resolved-[1H,  1H]
NOESY (100 ms mixing time) and 3D 15N resolved-[1H,
1H] TOCSY (70 ms mixing time) together with analysis of
HCCH-TOCSY experiments allowed to assign proton side
chains.
HN, NH and Cα backbone atoms of the Ship2-Sam/Arap3-
Sam complex were identified in HNCA experiments
acquired on samples containing either 15N/13C double
labeled Ship2-Sam at a concentration of 1 mM and unla-
beled Arap3-Sam at a concentration of 1 mM or double
labeled Arap3-Sam (1 mM concentration) and unlabeled
Ship2-Sam (1 mM concentration). Stereo-specific assign-
ments for Leu-CH3
δ 1,2 and Val-CH3
γ 1,2 methyl groups of
Arap3-Sam were obtained by recording a 2D [1H, 13C]-
HSQC experiment of a fractionally 13C labeled Arap3-Sam
sample at a concentration of 1 mM [27].
Relaxation measurements
Experiments for measuring backbone 15N nuclear spin
relaxation parameters, were recorded at 25°C on a 600
MHz Bruker Avance DRX spectrometer equipped with a
TXI probe. Longitudinal relaxation rates (R1) and trans-
verse relaxation rates (R2) were obtained for 15N-labeled
samples of Arap3-Sam at the concentrations of 150 μM
and 1.4 mM and for a sample of the Sam-Sam complex
containing 15N-labeled Ship2-Sam (1 mM) and unlabeled
Arap3-Sam (2 mM). R1 and R2 relaxation data were col-
lected and analyzed as we have previously reported for the
Ship2-Sam and EphA2-Sam interaction [10]. Briefly, five
relaxation delays (0.01, 0.1, 0.3, 0.6, 1.0 s) were used for
R1 measurements; and seven relaxation delays were
implemented for R2 data sets (i.e., 0.01, 0.03, 0.05, 0.07,
0.11, 0.15, 0.19 s). The rotational correlation time was
estimated with the software tmest (Palmer A. G. III,
Columbia University) by using the average R2/R1 values.
Solution structure of Arap3-Sam
Structure calculations were performed with the program
CYANA version 2.1 [30]. A 3D-15N resolved [1H,  1H]
NOESY-HSQC spectrum [31] (100 ms mixing time)
together with a 3D 13C resolved [1H, 1H] NOESY-HSQC
spectrum (150 ms mixing time) and 2D [1H, 1H] NOESY
[32] (100 ms mixing time), for the aliphatic to aromatic
region, that was recorded after dissolving the lyophilized
protein sample in 99% D2O, were used to obtain distance
constraints. Structure calculations were initiated from 100
random conformers; the 20 structures with the lowest
CYANA target functions were analyzed with the programs
MOLMOL [33] and PROCHECK-NMR [34]. Colour fig-
ures were produced with MOLMOL [33]. MOLCAD [35],
as implemented in Sybyl, was used to generate surface rep-
resentations. NMR structures have been deposited in the
Protein Data Bank under accession code 2KG5.
NMR Binding studies
Chemical shifts perturbation studies by means of 2D [1H,
15N]-HSQC were carried out to study the protein-protein
interaction [15,16]. First, 15N-labeled Ship2-Sam (200 μM
concentration) was titrated with increasing amounts of
unlabeled Arap3-Sam (50, 74, 130, 186, 233 μM). Then,
a 15N labeled Arap3-Sam sample (200 μM concentration)
was titrated with unlabeled Ship2-Sam (concentrations:
50, 100, 200 μM). Details on the NMR chemical shift per-
turbation studies with the Arap3-Sam triple mutant are
reported in the Additional File 2.BMC Structural Biology 2009, 9:59 http://www.biomedcentral.com/1472-6807/9/59
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2D spectra were compared with the program Sparky (T. D.
Goddard and D. G. Kneller, SPARKY 3, University of Cal-
ifornia, San Francisco).
Isothermal titration calorimetry
ITC measurements were carried out at 25°C with a VP-ITC
apparatus (Microcal, USA). The Shiptide (Ac-EGLVHNG-
WDDLEFLSDITEEDL-NH2) [10], was purchased by the
Protein/DNA Facility of the Medical College of Wisconsin.
A solution of peptide (1 mM concentration) was titrated
into a solution of Arap3-Sam at a concentration of 75 μM.
For these studies, the peptide was dissolved in 1 × PBS at
pH = 7.7 and Arap3-Sam was extensively dialyzed in the
same buffer.
ITC experiments were repeated twice to evaluate the
reproducibility of the data. Data were fit to a standard one
binding site model using Origin as supplied by Microcal.
Analytical ultracentrifugation
A Beckman ProteomeLab™ Optima XL-I analytical ultra-
centrifuge was used to carry out sedimentation equilib-
rium analysis. Three runs were performed by using
samples with protein concentrations of 1 mg/ml, 0.33
mg/ml, and 0.11 mg/ml, respectively. Data were collected
at the angular velocity of 30,000 rpm and at 20°C. Data
were analyzed with the software HeteroAnalysis (James L.
Cole; http://www.biotech.uconn.edu/auf/).
Docking studies
The program Haddock 1.3 [18] was used to generate a
model of the Ship2-Sam/Arap3-Sam complex. The NMR
structures number one of both Ship2-Sam (pdb code:
2K4P, [10]) and Arap3-Sam (pdb code: 2KG5) were
implemented for these studies. Chemical shift perturba-
tion data were exploited to produce ambiguous interac-
tion restraints (AIR). Residues H47, N48, W50, D51, D52,
E54, F55, S57, D58, I59, T60, E61, E62, E66, Q70 of
Ship2-Sam were set as active. For Arap3-Sam, residues
H37, S70, T72, G73, K76, R77, R80, Q83 were considered
active, whereas H61, E62, E63, K65, Q66 were set as pas-
sive. Residues for the AIR restraints were chosen among
the ones with the greatest chemical shift perturbation
because they either show high solvent exposure (> 30% as
evaluated with MOLMOL [33]) or because they could pro-
vide interactions at the interface as shown in experimental
structures of Sam-Sam complexes. The limit for the AIR
restraints was kept to the default value of 2 Å. During the
rigid body energy minimization stage, 2000 structures
were calculated; in the second iteration a semi-flexible
simulated annealing of the best 200 solutions was per-
formed, finally a refinement in water was carried out. Seg-
ments 48-66 and 70-80 of Ship2-Sam and Arap3-Sam
respectively, were set as semi-flexible and movements of
their side-chains were permitted during the semi-rigid
body docking protocol. Besides, residues of the C-termi-
nal tail of Arap3-Sam (88-100) were set completely flexi-
ble during the whole docking calculation.
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Additional file 2
Chemical shift perturbation studies with the Arap3-Sam mutant. The 
comparison of 2D [1H, 15N]-HSQC spectra of 15N labeled Arap3-Sam 
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